Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy.
Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):947-58. doi: 10.1016/s0360-3016(99)00500-3.
Int J Radiat Oncol Biol Phys. 2000.
PMID: 10705017
Clinical Trial.
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.
Cokgor I, Akabani G, Kuan CT, Friedman HS, Friedman AH, Coleman RE, McLendon RE, Bigner SH, Zhao XG, Garcia-Turner AM, Pegram CN, Wikstrand CJ, Shafman TD, Herndon JE 2nd, Provenzale JM, Zalutsky MR, Bigner DD.
Cokgor I, et al. Among authors: garcia turner am.
J Clin Oncol. 2000 Nov 15;18(22):3862-72. doi: 10.1200/JCO.2000.18.22.3862.
J Clin Oncol. 2000.
PMID: 11078500
Clinical Trial.
Item in Clipboard
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
Friedman HS, Pluda J, Quinn JA, Ewesuedo RB, Long L, Friedman AH, Cokgor I, Colvin OM, Haglund MM, Ashley DM, Rich JN, Sampson J, Pegg AE, Moschel RC, McLendon RE, Provenzale JM, Stewart ES, Tourt-Uhlig S, Garcia-Turner AM, Herndon JE 2nd, Bigner DD, Dolan ME.
Friedman HS, et al. Among authors: garcia turner am.
J Clin Oncol. 2000 Oct 15;18(20):3522-8. doi: 10.1200/JCO.2000.18.20.3522.
J Clin Oncol. 2000.
PMID: 11032594
Clinical Trial.
Item in Clipboard
Cite
Cite